Journal of the American Pharmacists Association最新文献

{"title":"Barriers to and Facilitators of Buprenorphine Dispensing for Opioid Use Disorder: Evidence from Focus Groups in Appalachian Kentucky.","authors":"Douglas R Oyler, Dustin K Miracle, Hannah Hesener, Laura Stinson, Monica Roberts, Adrienne Matson, Patricia R Freeman","doi":"10.1016/j.japh.2024.102308","DOIUrl":"10.1016/j.japh.2024.102308","url":null,"abstract":"<p><strong>Background: </strong>As efforts to increase buprenorphine prescribing continue to intensify, pharmacy dispensing plays an important role in access to essential medications for opioid use disorder. Existing survey research suggests stigma and regulatory concerns are barriers to pharmacists dispensing buprenorphine, but facilitators are less clear, as are in-depth perceptions of pharmacists regarding buprenorphine.</p><p><strong>Objective: </strong>To assess barriers and facilitators to buprenorphine dispensing in Appalachian Kentucky using a series of focus groups with pharmacy employees.</p><p><strong>Methods: </strong>Between September and October 2023, five structured focus groups were conducted with a total of 19 pharmacists and pharmacy technicians across a mixture of high- and low-buprenorphine-dispensing counties. Investigators independently coded focus group transcriptions using a grounded theory approach to describe current dispensing practices as well as barriers to and facilitators of buprenorphine dispensing.</p><p><strong>Results: </strong>Most participants described dispensing buprenorphine, but there was substantial variation in dispensing practices. Participants identified patient-, provider-, pharmacy-, regulatory-and medication-related barriers to and patient-, provider-, pharmacy-, and regulatory-related facilitators of pharmacy dispensing. Patient- and provider-related barriers accounted for over half of barriers identified. The most common facilitators were also patient- and provider-related.</p><p><strong>Conclusion: </strong>In a series of 5 focus groups with pharmacy staff in Appalachian Kentucky, the most common barriers to buprenorphine dispensing were patient and provider behaviors. Patient stories were the most common facilitators. Interventions to increase pharmacy buprenorphine dispensing should focus on addressing misperceptions regarding behavior, preferably driven by positive patient testimony.</p>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":" ","pages":"102308"},"PeriodicalIF":2.5,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142792703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Community pharmacists' experiences regarding the treatment management of people with diabetes during Ramadan: A phenomenological study.","authors":"Elif Ulutas Deniz, Ceren Ceylan, Hatice Seda Kaya","doi":"10.1016/j.japh.2024.102303","DOIUrl":"10.1016/j.japh.2024.102303","url":null,"abstract":"<p><strong>Background: </strong>Community pharmacists are often the first point of contact for patients seeking assistance in managing chronic diseases, including diabetes, owing to their accessibility. They are readily available to patients, especially in outpatient settings, and can play a vital role in ensuring safe medication use in patients with diabetes. However, published research on the role of community pharmacists in managing diabetes in patients fasting during Ramadan in Türkiye and worldwide is limited.</p><p><strong>Objectives: </strong>The aim of this study was to investigate the perspectives and experiences of Turkish community pharmacists in providing treatment management for people with diabetes during Ramadan.</p><p><strong>Methods: </strong>To obtain in-depth information about community pharmacists' experiences and perspectives regarding the treatment management of patients with diabetes during Ramadan, a qualitative methodology was chosen for data collection, which could not be obtained using quantitative methods. To gather the views of community pharmacists, a carefully designed semi-structured interview guide was developed to conduct the qualitative interviews. Following the transcription and translation processes, interpretive phenomenological analysis was conducted as an integral part of the data analysis.</p><p><strong>Results: </strong>A total of 21 pharmacists participated in this study. Three main themes, along with their corresponding subthemes, emerged from the dataset: Advice from pharmacists to patients, challenges, and recommendations. The study revealed the professional services pharmacists provided and the barriers they encountered, and documented the recommendations they put forward regarding diabetes treatment management.</p><p><strong>Conclusion: </strong>Pharmacists reported providing diabetes-related services during Ramadan, such as dietary advice, medication adjustments, and dietitian referrals. However, they identified several significant challenges, including increased workload, patients' religious beliefs, and limited public awareness of their expertise. To address these, expanding pharmacists' roles, improving communication with patients and physicians, and incorporating Ramadan-specific diabetes management into pharmacy education are seen as key strategies for enhancing care.</p>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":" ","pages":"102303"},"PeriodicalIF":2.5,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacists' perceptions of artificial intelligence: A national survey.","authors":"Kyle A Gustafson, Casey Rowe, Paul Gavaza, Allison Bernknopf, Anna Nogid, Alexander Hoffman, Ellen Jones, Leanne Showman, Victoria Miller, May H Abdel Aziz, Damianne Brand-Eubanks, Duc P Do, Sarah Berman, Angela Chu, Vivek Dave, Radhika Devraj, Trager D Hintze, Faria Munir, Islam Mohamed, Motolani E Ogunsanya, Jarred Prudencio, Divita Singh, Robin Southwood","doi":"10.1016/j.japh.2024.102306","DOIUrl":"10.1016/j.japh.2024.102306","url":null,"abstract":"<p><strong>Background: </strong>Artificial intelligence (AI) is a rapidly growing and evolving field impacting pharmacy research, education, and professional practice. The development and adaptation of AI technologies have the potential to radically shape the future of the pharmacy profession. However, it remains unclear how aware pharmacists are of these technologies or their perceptions regarding current and future utilization.</p><p><strong>Objective: </strong>The purpose of this study is to describe the perceptions and awareness of artificial intelligence technologies in a population of practicing pharmacists across the United States.</p><p><strong>Methods: </strong>A 19-question electronic survey was administered via Qualtrics to assess various AI perceptions among U.S. pharmacists. The survey ran from September 5th to November 22nd, 2023 and targeted practicing pharmacists through professional organizations and publicly available email lists. Responses were analyzed for descriptive trends and demographic analysis focusing on factors predicting AI use and were categorized into sub-focuses for detailed analysis.</p><p><strong>Results: </strong>A total of 1363 practicing pharmacists completed the survey. 82.5% of respondents expressed some degree of familiarity with AI software, but only 38.7% reported having used AI. Of those using AI software, the most common applications were Large Language Models (33.7%) and Image Generation (10%). 56.1% of pharmacists feel that AI will decrease the number of pharmacy jobs, and 34.9% of pharmacists express some degree of distrust of AI. Despite this, 64.1% of pharmacists feel that AI could enhance their professional effectiveness and productivity. Males appear much more likely than females to use AI (50.1% Vs. 31%, P < .001). Younger responders also reported higher AI utilization with the highest utilization aged 23-29 (47.5%) and lowest in 60+ (25.6%, P < .001) CONCLUSION: Understanding pharmacists' current awareness, concerns, and perspectives on AI is crucial for navigating its potential impact on the profession including potential professional utilization, addressing concerns regarding job security, ethical considerations, and regulatory uncertainty.</p>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":" ","pages":"102306"},"PeriodicalIF":2.5,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142773688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacists' Answer to the COVID-19 Pandemic: Contribution of the Federal Retail Pharmacy Program to COVID-19 vaccination across Sociodemographic Characteristics-United States.","authors":"Roua El Kalach, Nkenge H Jones-Jack, John D Grabenstein, Mattie Elam, Abdulhakeem A Olorukooba, Amee K deMartino, Marley Vazquez, Shannon Stokley, Sarah A Meyer, Teresa W Wang, Andrew Himsel, Connor Medernach, Kendra Jenkins, Stacey Marovich, Meranda D Bradley, Brian J Manns, Doug Romerhausen, Lori B Moore","doi":"10.1016/j.japh.2024.102305","DOIUrl":"10.1016/j.japh.2024.102305","url":null,"abstract":"<p><strong>Background: </strong>The Federal Retail Pharmacy Program (FRPP) integrated pharmacies as partners in the national effort to maximize vaccination during the COVID-19 public health emergency.</p><p><strong>Objective: </strong>The objective of this study was to quantify the contribution of pharmacies participating in FRPP to COVID-19 vaccination efforts during December 2020-September 2023 across sociodemographic groups in the United States.</p><p><strong>Methods: </strong>Data on COVID-19 vaccine doses administered reported to Centers for Disease Control and Prevention by FRPP and jurisdictional immunization information systems of all 50 states, the District of Columbia, and U.S. territories were analyzed to estimate FRPP contributions.</p><p><strong>Results: </strong>Approximately 314.9 million COVID-19 vaccine doses were administered by FRPP throughout this period, constituting 48.9% of all COVID-19 vaccine doses administered. FRPP contributions to COVID-19 vaccination ranged from 12.9% to 56.8% for persons aged 6 months-4 years and 12-17 years, respectively. FRPP made the highest contribution to administering COVID-19 doses to Non-Hispanic Asian (48.7%) and Hispanic/Latino (49.8%) persons. The proportion of COVID-19 doses given by FRPP pharmacies was found to be higher in urban areas (57%) compared with rural areas (45%).</p><p><strong>Conclusion: </strong>FRPP administered a substantial proportion of COVID-19 vaccine doses in the United States and provided vaccine access for persons across a wide range of groups. Pharmacies can complement vaccination efforts during public health emergency situations and in routine vaccination programs.</p>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":" ","pages":"102305"},"PeriodicalIF":2.5,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Implementation of a specialty pharmacy in an ambulatory care setting in Saudi Arabia: Patient experience and operational outcomes.","authors":"Abdulrazaq S Al-Jazairi, Roa'a Al-Gain, Nasser I Alrubayan, Alhanouf F Almousa, Lina M Aldawood, Reem A Alshammari, Ghayda H Alzaidi, Qasem A Bahri, Sakra S Balhareth, Norah Almalhooq, Yousef Binamer, Hisham Alomran","doi":"10.1016/j.japh.2024.102302","DOIUrl":"10.1016/j.japh.2024.102302","url":null,"abstract":"<p><strong>Background: </strong>Specialty pharmacy practice requires unique patient-centric care, emphasizing high-cost medications, complex treatment regimens, and medications requiring special handling.</p><p><strong>Objective: </strong>We conducted this study to assess the effect of specialty pharmacy practice on patient and healthcare provider (HCP) satisfaction and pharmacy practice-related outcomes.</p><p><strong>Methods: </strong>This prospective, concurrent, and historically controlled cohort study was performed in an ambulatory care setting for over 6 months and included 6 specialties: neurology, pediatrics, dermatology, gastroenterology, pediatric liver transplantation, and medical genetics. The workflow of the pharmacy was redesigned to serve the objective of specialized counseling and dispensing windows. Patients who visited selected clinics during the study period were included. The primary endpoint was the weighted scores for patient and HCP satisfaction obtained via a validated satisfaction survey. The secondary endpoints included pharmacy operation-related outcomes, such as patient's waiting time, pharmacist intervention, and patient adherence to specialty medications.</p><p><strong>Results: </strong>Of the 3827 patients approached for study participation, 3620 were recruited (94.5%). Of the 175 HCPs approached, 161 were recruited. Patient satisfaction scores improved from 4.27 to 4.69 after intervention (P < 0.05). Although there was no significant change in pharmacists' satisfaction, a significant improvement in other HCP satisfaction was observed (3.7-4; P = 0.008). The average wait time was reduced from 25 to 12 min (P < 0.05). The number of documented pharmacist interventions was 3 per 100 patients. Patient adherence improved from 73.6% to 85.6% based on the number of days covered (P = 0.03).</p><p><strong>Conclusion: </strong>Implementing specialty pharmacies improved the overall satisfaction of patients and health care providers and enhanced work efficiency, as demonstrated by reduced pharmacy waiting time and patient adherence to specialty medications.</p>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":" ","pages":"102302"},"PeriodicalIF":2.5,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Risk stratification of potential drug interactions involving common over-the-counter medications and herbal supplements by a large language model.","authors":"John Kim, John W R Kincaid, Arya S Rao, Winston Lie, Lanting Fuh, Adam B Landman, Marc D Succi","doi":"10.1016/j.japh.2024.102304","DOIUrl":"10.1016/j.japh.2024.102304","url":null,"abstract":"<p><strong>Background: </strong>As polypharmacy, the use of over-the-counter (OTC) drugs, and herbal supplements becomes increasingly prevalent, the potential for adverse drug-drug interactions (DDIs) poses significant challenges to patient safety and health care outcomes.</p><p><strong>Objective: </strong>This study evaluates the capacity of Generative Pre-trained Transformer (GPT) models to accurately assess DDIs involving prescription drugs (Rx) with OTC medications and herbal supplements.</p><p><strong>Methods: </strong>Leveraging a popular subscription-based tool (Lexicomp), we compared the risk ratings assigned by these models to 43 Rx-OTC and 30 Rx-herbal supplement pairs.</p><p><strong>Results: </strong>Our findings reveal that all models generally underperform, with accuracies below 50% and poor agreement with Lexicomp standards as measured by Cohen's kappa. Notably, GPT-4 and GPT-4o demonstrated a modest improvement in identifying higher-risk interactions compared to GPT-3.5.</p><p><strong>Conclusion: </strong>These results highlight the challenges and limitations of using off-the-shelf large language models for guidance in DDI assessment.</p>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":" ","pages":"102304"},"PeriodicalIF":2.5,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142755781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development of a productivity model at a pharmacy consolidated service center.","authors":"Amelia Hornaday, Philipp Monterroyo, Lindsay Reulbach, Catherine Bishop, Harrison Jozefczyk","doi":"10.1016/j.japh.2024.102298","DOIUrl":"10.1016/j.japh.2024.102298","url":null,"abstract":"<p><strong>Background: </strong>Health systems have implemented pharmacy consolidated service centers (PCSCs) to address increased patient volume, elevated drug costs, and decreased reimbursements. Assessing pharmacy productivity remains a challenge given that metrics have historically been determined by calculations of variables that do not capture the actual work. Several investigators have demonstrated improved labor outcomes in health-system pharmacy with the use of novel productivity models. However, the utility of a novel productivity model at a PCSC has not been assessed.</p><p><strong>Objective: </strong>This study aimed to develop a productivity model with validation by comparison to past time periods to represent work at a PCSC.</p><p><strong>Methods: </strong>The amount of time needed to complete work was determined by performing time studies. A modified Delphi process was used to ensure an appropriate perception of workload. Time standards for each category were averaged to determine the specific relative value units, which were then multiplied by total biweekly orders and combined with fixed activities to determine the unit of service. Actual hours worked were obtained for 6 prior pay periods to compare tool productivity with actual productivity.</p><p><strong>Results: </strong>Time studies were performed over a 3-month period. The total average hours per pay period calculated by the tool for repackaging was 167.4 or 2.1 full-time equivalents (FTEs) and for warehousing was 176.8 or 2.2 FTEs. Although tool productivity followed the same trends as historical calendar day productivity, it was consistently higher per pay period over the 12-week comparison.</p><p><strong>Conclusion: </strong>By performing time studies, a productivity model was developed for a PCSC that generated productivity data that correlated with 12 weeks of data using a historical model. This study provides the ability to assess trends over time with a more precise evaluation of work leading to the discussion that this tool is superior to historical productivity models.</p>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":" ","pages":"102298"},"PeriodicalIF":2.5,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142752096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perceptions of PGY1 residency program directors toward online pharmacy students.","authors":"Mohammad Sajjad, Michael R Gionfriddo, Branden D Nemecek","doi":"10.1016/j.japh.2024.102300","DOIUrl":"10.1016/j.japh.2024.102300","url":null,"abstract":"<p><strong>Background: </strong>While research has identified characteristics that improve students' chances of matching into a postgraduate year 1 (PGY1) residency, it is unclear how graduating from an online pharmacy program affects these chances.</p><p><strong>Objectives: </strong>Our qualitative descriptive study aimed to explore perceptions of residency program directors (RPDs) toward online pharmacy students and how these perceptions may affect match rankings.</p><p><strong>Methods: </strong>PGY1 RPDs were identified using the American Society of Health-System Pharmacists Residency Directory, recruited via email, and interviewed with a set of prespecified open-ended questions. Interviews were digitally recorded and transcribed, with transcripts being used to develop consensus codes and consequent themes and subthemes.</p><p><strong>Results: </strong>Fourteen RPDs from a variety of residency program types were interviewed. Most RPDs had positive or neutral perceptions towards online pharmacy programs. Their perceptions of the students in these programs were mixed, with some extolling drive and motivation, while others assuming laziness as motivation for pursuing an online program. RPDs mentioned that being in an online pharmacy program could negatively affect students' skills, such as patient care and communication skills, while others felt it could positively affect self-advocacy and time management skills. Despite these concerns, RPDs reiterated they use the same criteria and advice as they would for traditional students and that it would not affect their ranking.</p><p><strong>Conclusion: </strong>RPDs' perceptions toward online pharmacy programs and the students in them were mixed, with some being concerned the nature of these programs would negatively impact skills needed for residency. Despite these concerns, RPDs reiterated these students will be assessed no differently from traditional students.</p>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":" ","pages":"102300"},"PeriodicalIF":2.5,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142741174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Vaccination payments in states with provider status for pharmacists: A claims analysis.","authors":"Rachel Wittenauer, Jennifer L Bacci, Parth D Shah, Andy Stergachis","doi":"10.1016/j.japh.2024.102301","DOIUrl":"10.1016/j.japh.2024.102301","url":null,"abstract":"<p><strong>Background: </strong>Federal-level legislation to recognize pharmacists as providers and thus allow insurance reimbursement for health services claims, not just prescription drug claims (known as provider status), has been advocated for by the profession but is yet to be passed into federal law. Several state governments have enacted this recognition for commercial insurance and/or Medicaid plans. However, the impact of these laws on reimbursement and access to health services has yet to be explored empirically.</p><p><strong>Objective: </strong>Compare commercial reimbursements for influenza and herpes zoster vaccinations for adults in provider status vs. non-provider status states to determine whether these laws have had the intended effect of increasing reimbursement to pharmacists for provided services.</p><p><strong>Methods: </strong>We used pharmaceutical and outpatient services claims from a national claims database, Marketscan, to examine payments made to pharmacies for all codes billed during vaccination visits. We then used a multivariable logistic regression model to compare the net revenue of vaccination visits in commercial provider status states vs. non-commercial provider-status states.</p><p><strong>Results: </strong>Our dataset contained 2.3 million vaccination visits for influenza and herpes zoster during 2021-2022. We found that the odds of a vaccination visit having positive net revenue were slightly higher in provider status states (shingles odds ratio [OR]: 1.03, P < 0.001; influenza OR 1.01:, P < 0.001). These findings are limited by the stark lack of health services claims by pharmacies in our dataset; only 0.4% of visits included any outpatient services claims, even among provider status states.</p><p><strong>Conclusion: </strong>This indicates that pharmacists are not submitting claims for reimbursement to payors for health services they are providing. This absence could be due to several reasons and limits the ability to generate evidence about the effect of these laws on health and economic outcomes for patients and health systems. Further research is needed to identify and address barriers to implementation of provider status laws.</p>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":" ","pages":"102301"},"PeriodicalIF":2.5,"publicationDate":"2024-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An analysis of national news coverage of semaglutide for weight loss.","authors":"Michael R Gionfriddo, Katelyn M Owens, Hannah Banks, Anwitha Sherigar, Jordan R Covvey","doi":"10.1016/j.japh.2024.102297","DOIUrl":"10.1016/j.japh.2024.102297","url":null,"abstract":"<p><strong>Background: </strong>Glucagon-like peptide 1 (GLP-1) agonists like semaglutide have risen significantly in use in recent years as a therapeutic option for the management of obesity. Popular media serves as an information source for many patients, and depending on the content, may influence how a patient views a particular therapy.</p><p><strong>Objective: </strong>To describe the content of online/print news articles published about semaglutide for weight loss.</p><p><strong>Methods: </strong>Online websites and databases were used to access 8 major U.S. online/print news outlets, including the New York Times, Wall Street Journal, Washington Post, USA Today, Fox News, CNN, ABC News, and CBS News. Sources were searched for articles focusing on semaglutide and weight loss published in 2023. Articles were excluded if they focused on: (1) type 2 diabetes, (2) company press releases, or were (3) videos or transcripts of oral broadcasts/podcasts. A random sample of articles was chosen with equitable distribution across sources. Articles were assessed for the presence of data across 9 domains and 30 different content codes, stratified by news source.</p><p><strong>Results: </strong>A total of 127 articles were analyzed, split almost equally between print (n = 63) and online (n = 64) sources. The vast majority of articles were news articles/analyses (122; 96.1%). The most popular primary focus of articles were social/popular aspects of GLP-1 agonists (22; 17.3%), followed by basic medication information (20; 15.8%), harms of the medication (20; 15.8%), and benefits of the medication (17; 13.4%). Print sources were more likely to report on the cash price (55.6% Vs. 28.1%, P = 0.002), lack of insurance (61.9% Vs. 21.9%, P < 0.001), and cost-effectiveness (11.1% Vs. 1.6%, P = 0.027) of the medication compared to online sources.</p><p><strong>Conclusion: </strong>Online/print news articles regarding semaglutide for weight loss provide a variety of information about the medication, commonly focusing on social aspects of treatment.</p>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":" ","pages":"102297"},"PeriodicalIF":2.5,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142696016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}